PTC THERAPEUTICS INC (PTCT)       46.25  +0.26 (+0.57%)

46.25  +0.26 (+0.57%)

US69366J2006 - Common Stock - After market: 46.25 0 (0%)

News Image
7 days ago - PTC Therapeutics, Inc.

NICE recomenda reembolso para Translarna™

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) anunciou hoje que o National Institute for Health and Care Excellence (NICE) publicou um Documento de...

News Image
10 days ago - PTC Therapeutics, Inc.

NICE recomienda el reembolso de Translarna™

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) anunció hoy que el National Institute for Health and Care Excellence (NICE) ha publicado un documento de...

News Image
19 days ago - PTC Therapeutics, Inc.

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 5, 2023, the company approved non-statutory stock options to purchase an...

News Image
21 days ago - PTC Therapeutics, Inc.

PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will present an update on its commercial progress and R&D pipeline at the 41st Annual J.P. Morgan...

News Image
26 days ago - PTC Therapeutics, Inc.

PTC Therapeutics to Participate at 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 41st Annual J.P. Morgan...

News Image
2 months ago - InvestorPlace

7 Nasdaq Stocks to Sell Before They Plunge in 2023

While loyalty may be a positive trait in most circumstances, when it comes to Nasdaq stocks to sell, you got to look out for number one.

News Image
2 months ago - PTC Therapeutics, Inc.

Autoridade Reguladora Brasileira concede aprovação a Waylivra™ para Lipodistrofia Parcial Familiar

/PRNewswire/ -- A PTC Therapeutics, Inc. (NASDAQ: PTCT) anunciou hoje que a ANVISA (Agência Nacional de Vigilância Sanitária) aprovou o Waylivra™...

News Image
2 months ago - PTC Therapeutics, Inc.

La autoridad reguladora brasileña otorga su aprobación a Waylivra™ para tratar la lipodistrofia parcial familiar

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) anunció hoy que la Agencia Nacional de Vigilancia Sanitaria de Brasil, ANVISA (Agência Nacional de...

News Image
2 months ago - PTC Therapeutics, Inc.

Upstaza™ Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Upstaza™ (eladocagene exuparvovec) was granted authorization by the Medicines and...

News Image
3 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors...

News Image
3 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors...

News Image
3 months ago - Market News Video

PTC Therapeutics is Now Oversold (PTCT)

News Image
3 months ago - PTC Therapeutics, Inc.

PTC Provides Update on Ongoing Global PIVOT-HD Trial For PTC518

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) confirmed today that enrollment is active and ongoing for its Phase 2 PIVOT-HD trial of PTC518 for the...

News Image
4 months ago - PTC Therapeutics, Inc.

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2022 Financial Results

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its third quarter 2022...

News Image
4 months ago - PTC Therapeutics

Associação de pacientes brasileira recebe STRIVE(TM) Award 2022 da PTC Therapeutics para distrofia muscular de Duchenne

/PRNewswire/ -- A PTC Therapeutics, Inc. (NASDAQ: PTCT) anuncia que uma associação de pacientes brasileira é uma das quatro ganhadoras do programa global...